Keywords:
Motivation: Alzheimer's disease (AD) is the fifth-leading cause of death in the USA, with treatment options hampered by insensitive early diagnostics.
Goal(s): To develop a sensitive and stage specific diagnostic to identify regional alterations in neurovascular and metabolic regulation across the AD spectrum.
Approach: Retrospective multi-modal ASL-MRI and 18F-FDG PET were assessed for regional neurovascular and metabolic dysregulation across the AD spectrum described previously1, 2.
Results: AD animal models showed regional and stage dependent dysregulation1, 2, which was replicated in the current clinical study. MCI regions showed Type 1 and Type 2 uncoupling1, 2, while AD regions displayed prodromal and neuro-metabolic failure phenotypes.
Impact: Early diagnosis in AD is critical to develop a prophylactic treatment strategy, minimize morbidity, and mitigating healthcare financial burden. Our novel analytical method permits early non-invasive detection of regional neurovascular and metabolic dysregulation suitable for clinical staging and enrolment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords